vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and PJT Partners Inc. (PJT). Click either name above to swap in a different company.
PJT Partners Inc. is the larger business by last-quarter revenue ($531.4M vs $493.8M, roughly 1.1× Pediatrix Medical Group, Inc.). PJT Partners Inc. runs the higher net margin — 10.0% vs 6.8%, a 3.2% gap on every dollar of revenue. On growth, PJT Partners Inc. posted the faster year-over-year revenue change (12.9% vs -1.7%). Over the past eight quarters, PJT Partners Inc.'s revenue compounded faster (27.5% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
MD vs PJT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $531.4M |
| Net Profit | $33.7M | $53.4M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 23.1% |
| Net Margin | 6.8% | 10.0% |
| Revenue YoY | -1.7% | 12.9% |
| Net Profit YoY | 10.5% | 4.0% |
| EPS (diluted) | $0.40 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $531.4M | ||
| Q3 25 | $492.9M | $442.3M | ||
| Q2 25 | $468.8M | $401.1M | ||
| Q1 25 | $458.4M | $321.9M | ||
| Q4 24 | $502.4M | $470.5M | ||
| Q3 24 | $511.2M | $320.3M | ||
| Q2 24 | $504.3M | $358.1M | ||
| Q1 24 | $495.1M | $327.1M |
| Q4 25 | $33.7M | $53.4M | ||
| Q3 25 | $71.7M | $39.8M | ||
| Q2 25 | $39.3M | $32.9M | ||
| Q1 25 | $20.7M | $54.0M | ||
| Q4 24 | $30.5M | $51.3M | ||
| Q3 24 | $19.4M | $22.1M | ||
| Q2 24 | $-153.0M | $28.3M | ||
| Q1 24 | $4.0M | $32.6M |
| Q4 25 | 9.9% | 23.1% | ||
| Q3 25 | 13.8% | 20.6% | ||
| Q2 25 | 12.8% | 19.1% | ||
| Q1 25 | 7.0% | 16.3% | ||
| Q4 24 | 7.8% | 21.9% | ||
| Q3 24 | 6.6% | 15.4% | ||
| Q2 24 | -31.3% | 18.0% | ||
| Q1 24 | 3.2% | 16.5% |
| Q4 25 | 6.8% | 10.0% | ||
| Q3 25 | 14.5% | 9.0% | ||
| Q2 25 | 8.4% | 8.2% | ||
| Q1 25 | 4.5% | 16.8% | ||
| Q4 24 | 6.1% | 10.9% | ||
| Q3 24 | 3.8% | 6.9% | ||
| Q2 24 | -30.3% | 7.9% | ||
| Q1 24 | 0.8% | 10.0% |
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $-1.84 | — | ||
| Q1 24 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $538.9M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $308.2M |
| Total Assets | $2.2B | $1.8B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $538.9M | ||
| Q3 25 | $340.1M | $400.5M | ||
| Q2 25 | $224.7M | $214.6M | ||
| Q1 25 | $99.0M | $194.3M | ||
| Q4 24 | $229.9M | $483.9M | ||
| Q3 24 | $103.8M | $148.8M | ||
| Q2 24 | $19.4M | $164.2M | ||
| Q1 24 | $8.0M | $215.5M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $308.2M | ||
| Q3 25 | $890.7M | $228.6M | ||
| Q2 25 | $833.8M | $167.4M | ||
| Q1 25 | $789.2M | $148.8M | ||
| Q4 24 | $764.9M | $187.0M | ||
| Q3 24 | $732.5M | $159.1M | ||
| Q2 24 | $706.5M | $133.8M | ||
| Q1 24 | $856.2M | $174.6M |
| Q4 25 | $2.2B | $1.8B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $2.1B | $1.5B | ||
| Q1 25 | $2.0B | $1.4B | ||
| Q4 24 | $2.2B | $1.6B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $2.0B | $1.4B | ||
| Q1 24 | $2.2B | $1.3B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $155.7M |
| Free Cash FlowOCF − Capex | — | $138.6M |
| FCF MarginFCF / Revenue | — | 26.1% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.92× |
| TTM Free Cash FlowTrailing 4 quarters | — | $480.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $155.7M | ||
| Q3 25 | $137.3M | $256.1M | ||
| Q2 25 | $137.2M | $190.4M | ||
| Q1 25 | $-117.5M | $-75.9M | ||
| Q4 24 | $133.0M | $195.7M | ||
| Q3 24 | $91.8M | $180.5M | ||
| Q2 24 | $107.0M | $193.6M | ||
| Q1 24 | $-125.2M | $-38.8M |
| Q4 25 | — | $138.6M | ||
| Q3 25 | — | $240.9M | ||
| Q2 25 | — | $178.9M | ||
| Q1 25 | — | $-77.9M | ||
| Q4 24 | — | $195.3M | ||
| Q3 24 | — | $178.5M | ||
| Q2 24 | — | $193.0M | ||
| Q1 24 | — | $-39.2M |
| Q4 25 | — | 26.1% | ||
| Q3 25 | — | 54.5% | ||
| Q2 25 | — | 44.6% | ||
| Q1 25 | — | -24.2% | ||
| Q4 24 | — | 41.5% | ||
| Q3 24 | — | 55.7% | ||
| Q2 24 | — | 53.9% | ||
| Q1 24 | — | -12.0% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 3.39× | 2.92× | ||
| Q3 25 | 1.91× | 6.43× | ||
| Q2 25 | 3.49× | 5.79× | ||
| Q1 25 | -5.66× | -1.41× | ||
| Q4 24 | 4.36× | 3.81× | ||
| Q3 24 | 4.72× | 8.15× | ||
| Q2 24 | — | 6.84× | ||
| Q1 24 | -31.03× | -1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PJT
Segment breakdown not available.
